Product image of Xgeva (Denosumab) supplied by GNH India

Xgeva

Active Ingredient:
Denosumab
Origin:
EU

Xgeva (Denosumab)

Xgeva (denosumab) is a prescription medication used to help prevent bone complications in patients with bone metastases from solid tumors. It belongs to a class of drugs known as RANK ligand inhibitors. Xgeva is administered as a subcutaneous injection.

Manufacturer / TM Owner

Amgen Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xgeva is commonly used to reduce the risk of bone fractures, spinal cord compression, and other bone-related complications in patients with bone metastases from solid tumors. It is also used to treat giant cell tumor of bone in adults and skeletally mature adolescents. Patients often ask, 'what is Xgeva used for' to understand its role in managing bone health during cancer treatment.

Side Effects

  • Xgeva works by slowing bone breakdown and helping to maintain stronger bones. Many patients experience improved bone stability and reduced pain associated with bone metastases. The medication supports overall skeletal health during cancer therapy.

Precautions & Warnings

  • Xgeva should be used under medical supervision, as it may cause low calcium levels in the blood. Patients with a history of kidney problems or those taking other bone medications should discuss risks with their healthcare provider. Regular monitoring may be required during treatment.

Avoid Interactions

  • Xgeva may interact with other medications that affect bone metabolism, such as bisphosphonates or corticosteroids. Patients should inform their doctor about all prescriptions, over-the-counter drugs, and supplements. Alcohol and tobacco use may also influence bone health during treatment.

Frequently Asked Questions

Xgeva is given as a subcutaneous injection by a healthcare professional. The injection site is typically the upper arm, thigh, or abdomen.

Common side effects may include fatigue, nausea, and low calcium levels. Patients should report any unusual symptoms to their doctor.

Xgeva is often used alongside other cancer therapies. Your healthcare team will determine the best treatment plan for your condition.

The dosing schedule for Xgeva is typically once every 4 weeks. Your doctor will decide the frequency based on your medical needs.

Patients with low blood calcium levels or a history of severe allergic reactions to denosumab should avoid Xgeva. Always consult your healthcare provider before starting treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Denosumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT